Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial
Titel:
Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial
Auteur:
Usmani, Saad Z Hoering, Antje Ailawadhi, Sikander Sexton, Rachael Lipe, Brea Hita, Sandi Fredette Valent, Jason Rosenzweig, Michael Zonder, Jeffrey A Dhodapkar, Madhav Callander, Natalie Zimmerman, Todd Voorhees, Peter M Durie, Brian Rajkumar, S Vincent Richardson, Paul G Orlowski, Robert Z